Muna Anwar Alnimri, M.B.B.S.
Associate Professor, Department of Medicine
Specialties:
Nephrology,
Surgery - Transplant,
To see if Muna Anwar Alnimri is accepting new patients, or for assistance finding a UC Davis doctor, please call
800-2-UCDAVIS (800-282-3284).
Locations and Contact Info
UC Davis Medical Center
Additional Contact Numbers
Clinic Phone
Clinic Fax
Clinic Referral Phone
Physician Referrals
About Muna Anwar Alnimri
Specialties
Nephrology
Surgery - Transplant
Department
Division
Nephrology
Transplant Nephrology
Clinic
Transplant
Center/Program Affiliation
Gender
Female
Languages Spoken
Arabic
Bio
Philosophy of Care
Dr. Alnimri believes that patients can contribute to their own health care and help make decisions easier by interacting with their physicians, direct communications with health care provider builds trust much needed for ultimate excellent outcomes.
Clinical Interests
Dr Alnimri is a Transplant Nephrologist offering care to adults with kidney and Pancreas transplant. She evaluates patients for kidney and pancreas transplant and those interested in living kidney donation.
Research/Academic Interests
Dr. Alnimri is interested in clinical trials about new immunosuppression in the pipe line also desensitization protocols, follow up of living kidney donors and finding ways to diagnose rejection without doing kidney biopsies.
Education
Board Certifications
American Board of Internal Medicine, Board Certified, 2008, 2018
American Board of Nephrology, Board Certified, 2009, 2019
Medical School
M.B.B.S., Jordan University School of Medicine, Amman, Jordan 1987
Internship
Internal Medicine, Unity Health System, Rochester NY 2006-2008
Residency
Internal Medicine, Unity Health System, Rochester NY 2006-2008
Fellowships
Nephrology, Oregon Health Sciences University, Portland OR 1997-1999
Transplant Nephrology, UC San Francisco, San Francisco CA 2008-2009
Professional Memberships
American Society of Nephrology
American Society of Transplantation
Royal College of Physicians (UK)
Honors and Publications
Honors and Awards
Fellow of the Royal College of Physicians UK, 2005
Honorary Registrar University College, London, 2001
Select Recent Publications
Jespersen Nizamic T, Huang Y, Alnimri M, Cheng M, Chen LX, Jen KY. COVID-19 Manifesting as Renal Allograft Dysfunction, Acute Pancreatitis, and Thrombotic Microangiopathy: A Case Report. Transplant Proc. 2021 May;53(4):1211-1214. doi:10.1016/j.transproceed.2020.10.048. Epub 2020 Dec 18. PMID:33436168.
Howard JH 3rd, Darrow M, Chen LX, Alnimri M, Jen KY. Tonsillar Kaposi sarcoma in a renal transplant patient. Transpl Infect Dis. 2020 Oct;22(5):e13347. doi:10.1111/tid.13347. Epub 2020 Jun 16. PMID:32495980.
Freidman G, Moss O, Alnimri M, Chen L. Determination of type 2 DM risk in potential living kidney donors : A single center protocol and experience. Transplantation. 2020 Sep;104(S3):S87-S88.
Chen LX, De Mattos A, Bang H, Vu CT, Gandhi M, Alnimri M, Gallay B, Fananapazir G. Angioplasty vs stent in the treatment of transplant renal artery stenosis. Clin Transplant. 2018 Apr;32(4):e13217. doi:10.1111/ctr.13217. Epub 2018 Feb 28. PMID:29394514.
Alnimri M, Laftavi MR, Kohli R, Said M, Feng L, Patel S, Pankewycz O. African-American women and older patients are at risk for a greater decline in renal function following living kidney donation. Transplant Proc. 2011 Mar;43(2):512-5. doi:10.1016/j.transproceed.2011.01.041. PMID:21440747.
Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up. Transplant Proc. 2011 Mar;43(2):458-61. doi:10.1016/j.transproceed.2011.01.035. PMID:21440733.
Patel S, Pankewycz O, Kohli R, Said M, Alnimri M, Feng L, Laftavi MR. Obesity in renal transplantation: the role of induction therapy on long-term outcomes. Transplant Proc. 2011 Mar;43(2):469-71. doi:10.1016/j.transproceed.2011.01.040. PMID:21440736.
Laftavi MR, Hai F, Laftavi H, Feng L, Said M, Patel S, Kohli R, Alnimri M, Dayton M, Pankewycz O. Mycophenolic acid dose reductions result in poor long-term renal allograft survival: comparison between mycophenolate sodium and mycophenolate mofetil. Transplant Proc. 2011 Mar;43(2):478-81. doi:10.1016/j.transproceed.2011.01.037. PMID:21440738.
Laftavi MR, Patel S, Soliman MR, Alnimri M, Kohli R, Said M, Pankewycz O. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy. Transplant Proc. 2011 Mar;43(2):466-8. doi:10.1016/j.transproceed.2011.01.039. PMID:21440735.
Pankewycz O, Leca N, Kohli R, Wallace PK, Said M, Feng L, Alnimri M, Patel S, Laftavi MR. Low-dose rabbit antithymocyte globulin induction therapy results in prolonged selective lymphocyte depletion irrespective of maintenance immunosuppression. Transplant Proc. 2011 Mar;43(2):462-5. doi:10.1016/j.transproceed.2011.01.034. PMID:21440734.